Research Applications
Anti-Wrinkle Cosmeceutical
Clinical studies demonstrate 52% wrinkle reduction at 4% concentration after 28 days. Most effective for forehead and periorbital wrinkles.
Topical Muscle Relaxant Research
Studied as a topical approach to reduce expression line formation.
Mechanism of Action
SYN-AKE competitively antagonizes the muscle-type nicotinic acetylcholine receptor (α1β1δε nAChR) at the neuromuscular junction. By blocking acetylcholine binding on the postsynaptic (muscle) side, it reduces end-plate potential amplitude and muscle contraction force. The effect is reversible and partial, producing relaxation without complete paralysis.
Biological Pathways
Competitive antagonism at α1-subunit nAChR binding site. Reduced end-plate potential. Partial neuromuscular blockade.
Dosage Information
Calculation Results
Syringe Fill Level (100u syringe)
Protocols
No protocols featuring this peptide yet.
Browse All ProtocolsStability & Storage
Stable in cosmetic formulations. Store at room temperature. Compatible with standard cosmetic ingredients and formulations.
Side Effects & Precautions
Well-tolerated topically. No systemic absorption at cosmetic concentrations. Rare mild skin irritation.
Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.
Regulatory Status
Approved cosmetic ingredient (INCI: Dipeptide Diaminobutyroyl Benzylamide Diacetate). Used in commercial anti-aging products.
Research Studies
SYN-AKE: A Peptide Mimicking Waglerin-1 for Expression Line Reduction
Pentapharm DSM Technical Documentation.
Related Peptides

Collagen Peptides
Hydrolyzed Collagen, Collagen Hydrolysate

GHK-Cu
Copper Peptide GHK-Cu, Glycyl-L-histidyl-L-lysine:copper(II) +3 more

Argireline
Acetyl Hexapeptide-8, Acetyl Hexapeptide-3

Bone Broth Peptides
Bone Broth Protein

Marine Collagen
Fish Collagen, Marine Collagen Peptides

Matrixyl
Palmitoyl Pentapeptide-4, Pal-KTTKS
